Flipping the script: The effects of opioid prescription monitoring on specialty‐specific provider behavior
Author
Abstract
Suggested Citation
DOI: 10.1002/hec.4446
Download full text from publisher
References listed on IDEAS
- Manasi Deshpande & Yue Li, 2019.
"Who Is Screened Out? Application Costs and the Targeting of Disability Programs,"
American Economic Journal: Economic Policy, American Economic Association, vol. 11(4), pages 213-248, November.
- Manasi Deshpande & Yue Li, 2017. "Who Is Screened Out? Application Costs and the Targeting of Disability Programs," NBER Working Papers 23472, National Bureau of Economic Research, Inc.
- Brendan Saloner & Colleen L. Barry, 2018. "Ending The Opioid Epidemic Requires A Historic Investment In Medication‐Assisted Treatment," Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 37(2), pages 431-438, March.
- Powell, David & Pacula, Rosalie Liccardo & Taylor, Erin, 2020.
"How increasing medical access to opioids contributes to the opioid epidemic: Evidence from Medicare Part D,"
Journal of Health Economics, Elsevier, vol. 71(C).
- David Powell & Rosalie Liccardo Pacula & Erin Taylor, 2015. "How Increasing Medical Access to Opioids Contributes to the Opioid Epidemic: Evidence from Medicare Part D," NBER Working Papers 21072, National Bureau of Economic Research, Inc.
- David Powell & Rosalie Liccardo Pacula & Erin Audrey Taylor, 2016. "How Increasing Medical Access to Opioids Contributes to the Opioid Epidemic Evidence from Medicare Part D," Working Papers WR-1169, RAND Corporation.
- Rosalie L. Pacula & David Powell & Paul Heaton & Eric L. Sevigny, 2015. "Assessing the Effects of Medical Marijuana Laws on Marijuana Use: The Devil is in the Details," Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 34(1), pages 7-31, January.
- Johanna Catherine Maclean & Brady P. Horn & Jonathan H. Cantor, 2020. "Business Cycles And Admissions To Substance Abuse Treatment," Contemporary Economic Policy, Western Economic Association International, vol. 38(1), pages 139-154, January.
- Greene, William, 2008. "Functional forms for the negative binomial model for count data," Economics Letters, Elsevier, vol. 99(3), pages 585-590, June.
- Hollingsworth, Alex & Ruhm, Christopher J. & Simon, Kosali, 2017.
"Macroeconomic conditions and opioid abuse,"
Journal of Health Economics, Elsevier, vol. 56(C), pages 222-233.
- Alex Hollingsworth & Christopher J. Ruhm & Kosali Simon, 2017. "Macroeconomic Conditions and Opioid Abuse," NBER Working Papers 23192, National Bureau of Economic Research, Inc.
- Lauren Hersch Nicholas & Johanna Catherine Maclean, 2019.
"The Effect of Medical Marijuana Laws on the Health and Labor Supply of Older Adults: Evidence from the Health and Retirement Study,"
Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 38(2), pages 455-480, March.
- Lauren Hersch Nicholas & Johanna Catherine Maclean, 2016. "The effect of medical marijuana laws on the health and labor supply of older adults: Evidence from the Health and Retirement Study," NBER Working Papers 22688, National Bureau of Economic Research, Inc.
- Anusua Datta & Dhaval Dave, 2017.
"Effects of Physician‐directed Pharmaceutical Promotion on Prescription Behaviors: Longitudinal Evidence,"
Health Economics, John Wiley & Sons, Ltd., vol. 26(4), pages 450-468, April.
- Anusua Datta & Dhaval M. Dave, 2013. "Effects of Physician-Directed Pharmaceutical Promotion on Prescription Behaviors: Longitudinal Evidence," NBER Working Papers 19592, National Bureau of Economic Research, Inc.
- Powell, David & Pacula, Rosalie Liccardo & Jacobson, Mireille, 2018.
"Do medical marijuana laws reduce addictions and deaths related to pain killers?,"
Journal of Health Economics, Elsevier, vol. 58(C), pages 29-42.
- David Powell & Rosalie Liccardo Pacula & Mireille Jacobson, 2015. "Do Medical Marijuana Laws Reduce Addictions and Deaths Related to Pain Killers?," NBER Working Papers 21345, National Bureau of Economic Research, Inc.
- Callaway, Brantly & Sant’Anna, Pedro H.C., 2021.
"Difference-in-Differences with multiple time periods,"
Journal of Econometrics, Elsevier, vol. 225(2), pages 200-230.
- Brantly Callaway & Pedro H. C. Sant'Anna, 2018. "Difference-in-Differences with Multiple Time Periods," Papers 1803.09015, arXiv.org, revised Dec 2020.
- Thomas C. Buchmueller & Colleen M. Carey & Giacomo Meille, 2019. "How Well Do Doctors Know Their Patients? Evidence from a Mandatory Access Prescription Drug Monitoring Program," NBER Working Papers 26159, National Bureau of Economic Research, Inc.
- Marianne Bertrand & Esther Duflo & Sendhil Mullainathan, 2004.
"How Much Should We Trust Differences-In-Differences Estimates?,"
The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 119(1), pages 249-275.
- Marianne Bertrand & Esther Duflo & Sendhil Mullainathan, 2002. "How Much Should We Trust Differences-in-Differences Estimates?," NBER Working Papers 8841, National Bureau of Economic Research, Inc.
- Thomas C. Buchmueller & Colleen Carey, 2018.
"The Effect of Prescription Drug Monitoring Programs on Opioid Utilization in Medicare,"
American Economic Journal: Economic Policy, American Economic Association, vol. 10(1), pages 77-112, February.
- Thomas C. Buchmueller & Colleen Carey, 2017. "The Effect of Prescription Drug Monitoring Programs on Opioid Utilization in Medicare," NBER Working Papers 23148, National Bureau of Economic Research, Inc.
- Johanna Catherine Maclean & Brendan Saloner, 2019.
"The Effect of Public Insurance Expansions on Substance Use Disorder Treatment: Evidence from the Affordable Care Act,"
Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 38(2), pages 366-393, March.
- Maclean, J. Catherine & Saloner, Brendan, 2017. "The Effect of Public Insurance Expansions on Substance Use Disorder Treatment: Evidence from the Affordable Care Act," IZA Discussion Papers 10745, Institute of Labor Economics (IZA).
- Johanna Catherine Maclean & Brendan Saloner, 2017. "The Effect of Public Insurance Expansions on Substance Use Disorder Treatment: Evidence from the Affordable Care Act," NBER Working Papers 23342, National Bureau of Economic Research, Inc.
- Abby Alpert & David Powell & Rosalie Liccardo Pacula, 2018.
"Supply-Side Drug Policy in the Presence of Substitutes: Evidence from the Introduction of Abuse-Deterrent Opioids,"
American Economic Journal: Economic Policy, American Economic Association, vol. 10(4), pages 1-35, November.
- Abby Alpert & David Powell & Rosalie Liccardo Pacula, 2017. "Supply-Side Drug Policy in the Presence of Substitutes Evidence from the Introduction of Abuse-Deterrent Opioids," Working Papers WR-1181, RAND Corporation.
- Abby Alpert & David Powell & Rosalie Liccardo Pacula, 2017. "Supply-Side Drug Policy in the Presence of Substitutes: Evidence from the Introduction of Abuse-Deterrent Opioids," NBER Working Papers 23031, National Bureau of Economic Research, Inc.
- Sacks, Daniel W. & Hollingsworth, Alex & Nguyen, Thuy & Simon, Kosali, 2021.
"Can policy affect initiation of addictive substance use? Evidence from opioid prescribing,"
Journal of Health Economics, Elsevier, vol. 76(C).
- Daniel W. Sacks & Alex Hollingsworth & Thuy D. Nguyen & Kosali I. Simon, 2019. "Can Policy Affect Initiation of Addictive Substance Use? Evidence from Opioid Prescribing," NBER Working Papers 25974, National Bureau of Economic Research, Inc.
- Anca M. Grecu & Dhaval M. Dave & Henry Saffer, 2019.
"Mandatory Access Prescription Drug Monitoring Programs and Prescription Drug Abuse,"
Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 38(1), pages 181-209, January.
- Dhaval M. Dave & Anca M. Grecu & Henry Saffer, 2017. "Mandatory Access Prescription Drug Monitoring Programs and Prescription Drug Abuse," NBER Working Papers 23537, National Bureau of Economic Research, Inc.
- Jevay Grooms & Alberto Ortega, 2019. "Examining Medicaid Expansion and the Treatment of Substance Use Disorders," AEA Papers and Proceedings, American Economic Association, vol. 109, pages 187-192, May.
- Ashley C. Bradford & W. David Bradford, 2018. "The Impact of Medical Cannabis Legalization on Prescription Medication Use and Costs under Medicare Part D," Journal of Law and Economics, University of Chicago Press, vol. 61(3), pages 461-487.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Cohle, Zachary & Ortega, Alberto, 2023. "The effect of the opioid crisis on patenting," Journal of Economic Behavior & Organization, Elsevier, vol. 214(C), pages 493-521.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Alberto Ortega, 2023. "Medicaid Expansion and mental health treatment: Evidence from the Affordable Care Act," Health Economics, John Wiley & Sons, Ltd., vol. 32(4), pages 755-806, April.
- Johanna Catherine Maclean & Justine Mallatt & Christopher J. Ruhm & Kosali Simon, 2022.
"The Opioid Crisis, Health, Healthcare, and Crime: A Review of Quasi-Experimental Economic Studies,"
The ANNALS of the American Academy of Political and Social Science, , vol. 703(1), pages 15-49, September.
- Johanna Catherine Maclean & Justine Mallatt & Christopher J. Ruhm & Kosali I. Simon, 2022. "The Opioid Crisis, Health, Healthcare, and Crime: A Review Of Quasi-Experimental Economic Studies," NBER Working Papers 29983, National Bureau of Economic Research, Inc.
- Natali, Ilaria, 2024. "Economic Opportunity and Opioid Regulation: the Case of Codeine in France," TSE Working Papers 24-1563, Toulouse School of Economics (TSE).
- Maclean, Johanna Catherine & Tello-Trillo, Sebastian & Webber, Douglas, 2023.
"Losing insurance and psychiatric hospitalizations,"
Journal of Economic Behavior & Organization, Elsevier, vol. 205(C), pages 508-527.
- Johanna Catherine Maclean & Sebastian Tello-Trillo & Douglas Webber, 2019. "Losing Insurance and Psychiatric Hospitalizations," NBER Working Papers 25936, National Bureau of Economic Research, Inc.
- Johanna Catherine Maclean & D. Sebastian Tello-Trillo & Douglas A. Webber, 2022. "Losing insurance and psychiatric hospitalizations," Finance and Economics Discussion Series 2022-069, Board of Governors of the Federal Reserve System (U.S.).
- Pohl, R. Vincent, 2018.
"Time Trends Matter: The Case of Medical Cannabis Laws and Opioid Overdose Mortality,"
MPRA Paper
88219, University Library of Munich, Germany.
- Pohl, R. Vincent, 2018. "Time Trends Matter: The Case of Medical Cannabis Laws and Opioid Overdose Mortality," MPRA Paper 87237, University Library of Munich, Germany.
- David Beheshti, 2019. "Adverse health effects of abuse‐deterrent opioids: Evidence from the reformulation of OxyContin," Health Economics, John Wiley & Sons, Ltd., vol. 28(12), pages 1449-1461, December.
- Shishir Shakya & Collin Hodges, 2023. "Must‐access prescription drug monitoring programs and retail opioid sales," Contemporary Economic Policy, Western Economic Association International, vol. 41(1), pages 146-165, January.
- Bhashkar Mazumder, 2023. "The Effects of Prescription Drug Monitoring Programs on Labor Market Activity and Credit Outcomes," Working Paper Series WP 2023-13, Federal Reserve Bank of Chicago.
- Simone Balestra & Helge Liebert & Nicole Maestas & Tisamarie B. Sherry, 2021.
"Behavioral Responses to Supply-Side Drug Policy During the Opioid Epidemic,"
NBER Working Papers
29596, National Bureau of Economic Research, Inc.
- Balestra, Simone & Liebert, Helge & Maestas, Nicole & Sherry, Tisamarie B., 2022. "Behavioral Responses to Supply-Side Drug Policy During the Opioid Epidemic," IZA Discussion Papers 15221, Institute of Labor Economics (IZA).
- Simone Balestra & Helge Liebert & Nicole Maestas & Tisamarie B. Sherry, 2022. "Behavioral Responses to Supply-Side Drug Policy During the Opioid Epidemic," CESifo Working Paper Series 9704, CESifo.
- Powell, David & Pacula, Rosalie Liccardo & Taylor, Erin, 2020.
"How increasing medical access to opioids contributes to the opioid epidemic: Evidence from Medicare Part D,"
Journal of Health Economics, Elsevier, vol. 71(C).
- David Powell & Rosalie Liccardo Pacula & Erin Taylor, 2015. "How Increasing Medical Access to Opioids Contributes to the Opioid Epidemic: Evidence from Medicare Part D," NBER Working Papers 21072, National Bureau of Economic Research, Inc.
- David Powell & Rosalie Liccardo Pacula & Erin Audrey Taylor, 2016. "How Increasing Medical Access to Opioids Contributes to the Opioid Epidemic Evidence from Medicare Part D," Working Papers WR-1169, RAND Corporation.
- Sabia, Joseph J. & Dave, Dhaval & Alotaibi, Fawaz & Rees, Daniel I., 2024. "The effects of recreational marijuana laws on drug use and crime," Journal of Public Economics, Elsevier, vol. 234(C).
- Gal Wettstein, 2019. "Health insurance and opioid deaths: Evidence from the Affordable Care Act young adult provision," Health Economics, John Wiley & Sons, Ltd., vol. 28(5), pages 666-677, May.
- McMichael, Benjamin J. & Van Horn, R. Lawrence & Viscusi, W. Kip, 2020. "The impact of cannabis access laws on opioid prescribing," Journal of Health Economics, Elsevier, vol. 69(C).
- Ruhm, Christopher J., 2019. "Drivers of the fatal drug epidemic," Journal of Health Economics, Elsevier, vol. 64(C), pages 25-42.
- David Cho & Daniel I. García & Joshua Montes & Alison E. Weingarden, 2021. "Labor Market Effects of the Oxycodone-Heroin Epidemic," Finance and Economics Discussion Series 2021-025, Board of Governors of the Federal Reserve System (U.S.).
- Matthew T. Knowles, 2022. "How access to addictive drugs affects the supply of substance abuse treatment: Evidence from Medicare Part D," Health Economics, John Wiley & Sons, Ltd., vol. 31(8), pages 1649-1675, August.
- Cotti, Chad D. & Gordanier, John M. & Ozturk, Orgul D., 2020. "The relationship of opioid prescriptions and the educational performance of children," Social Science & Medicine, Elsevier, vol. 265(C).
- Christopher J. Ruhm, 2018. "Deaths of Despair or Drug Problems?," NBER Working Papers 24188, National Bureau of Economic Research, Inc.
- Johanna Catherine Maclean & Brady P. Horn & Jonathan H. Cantor, 2020. "Business Cycles And Admissions To Substance Abuse Treatment," Contemporary Economic Policy, Western Economic Association International, vol. 38(1), pages 139-154, January.
- Deiana Claudio & Giua Ludovica, 2021. "The Intended and Unintended Effects of Opioid Policies on Prescription Opioids and Crime," The B.E. Journal of Economic Analysis & Policy, De Gruyter, vol. 21(2), pages 751-792, April.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:wly:hlthec:v:31:y:2022:i:2:p:297-341. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Wiley Content Delivery (email available below). General contact details of provider: http://www3.interscience.wiley.com/cgi-bin/jhome/5749 .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.